Medpace Holdings (MEDP) EVP sells 7,500 shares of stock at $600
Rhea-AI Filing Summary
Medpace Holdings, Inc. executive Susan E. Burwig, Exec. VP, Operations, reported selling 7,500 shares of Common Stock on 2026-07-28 at $600 per share in a transaction described as open market or private.
After the sale, she directly owned 62,984 shares. The trade was executed under a limit order placed during an open window period.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 7,500 shares
Net Sell
1 txn
Insider
BURWIG SUSAN E
Role
Exec. VP, Operations
Sold
7,500 shs ($4.50M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 7,500 | $600.00 | $4.50M |
Holdings After Transaction:
Common Stock — 62,984 shares (Direct)
Footnotes (1)
- F1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
Key Figures
Shares sold: 7,500 shares
Sale price: $600.00 per share
Transaction value: $4,500,000
+2 more
5 metrics
Shares sold
7,500 shares
Common Stock sale on 2026-07-28 by Exec. VP, Operations
Sale price
$600.00 per share
Reported transaction price for the Common Stock sale
Transaction value
$4,500,000
Approximate gross value of 7,500 shares sold at $600
Shares owned after sale
62,984 shares
Directly owned Medpace Common Stock following the transaction
Net insider share change
-7,500 shares
Net shares sold across all non-derivative transactions in this filing
Key Terms
limit order, open window period, Rule 10b5-1, open market or private transaction
4 terms
limit order financial
"The transactions ... were effected pursuant to a limit order placed"
A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.
open window period financial
"limit order placed by the Reporting Person during an open window period"
Rule 10b5-1 financial
"Document-level Rule 10b5-1 checkbox (aff_10b5_one) was not marked"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction financial
"transaction code S: Sale in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Medpace (MEDP) disclose for Susan E. Burwig?
Susan E. Burwig, Medpace’s Exec. VP, Operations, reported selling 7,500 shares of Common Stock at $600 per share on 2026-07-28, characterized as an open market or private transaction and executed via a limit order during an open window.
Was the Medpace (MEDP) insider sale made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox was not marked, and a footnote states the trade was executed under a limit order placed during an open window period, rather than explicitly under a pre-arranged Rule 10b5-1 trading plan.
What does the limit order and open window period mean in the Medpace (MEDP) Form 4?
A footnote explains the sale occurred via a limit order placed during an open window period, indicating the order executed only at or above a specified price while the company’s trading window for insiders was open.